Guangzhou export categories for peptide intermediates were quietly renamed
Follow the resin, not the catalogue.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 4 of 4 of this archive, newest first.
Follow the resin, not the catalogue.
Reported from the analysis, not from a warning notice.
Follow the resin, not the catalogue.
The document is four pages. Three of them are about dates.
Reported from the analysis, not from a warning notice.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
The route did not close because of a rule about peptides.
A proper account of an operation that existed, and of what closing it cost.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Reported from the analysis, not from a warning notice.
The document is four pages. Three of them are about dates.
Reported from the sessions, and from the two hours afterwards.
Documentation practice is the only part of vendor quality a buyer can assess before purchase.
Efficacy was never the question in this appraisal. Duration of treatment was.
A proper account of an operation that existed, and of what closing it cost.
The evidence base is thin and the document says so, which is to its credit.
Follow the resin, not the catalogue.
The supplier has not disputed the finding. It has not explained the gap either.
Reported from the sessions, and from the two hours afterwards.
The document is four pages. Three of them are about dates.